<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32646955</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>25</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>A prospective harmonized multicenter DTI study of cerebral white matter degeneration in ALS.</ArticleTitle><Pagination><StartPage>e943</StartPage><EndPage>e952</EndPage><MedlinePgn>e943-e952</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000010235</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To evaluate progressive white matter (WM) degeneration in amyotrophic lateral sclerosis (ALS).</AbstractText><AbstractText Label="METHODS">Sixty-six patients with ALS and 43 healthy controls were enrolled in a prospective, longitudinal, multicenter study in the Canadian ALS Neuroimaging Consortium (CALSNIC). Participants underwent a harmonized neuroimaging protocol across 4 centers that included diffusion tensor imaging (DTI) for assessment of WM integrity. Three visits were accompanied by clinical assessments of disability (ALS Functional Rating Scale-Revised [ALSFRS-R]) and upper motor neuron (UMN) function. Voxel-wise whole-brain and quantitative tract-wise DTI assessments were done at baseline and longitudinally. Correction for site variance incorporated data from healthy controls and from healthy volunteers who underwent the DTI protocol at each center.</AbstractText><AbstractText Label="RESULTS">Patients with ALS had a mean progressive decline in fractional anisotropy (FA) of the corticospinal tract (CST) and frontal lobes. Tract-wise analysis revealed reduced FA in the CST, corticopontine/corticorubral tract, and corticostriatal tract. CST FA correlated with UMN function, and frontal lobe FA correlated with the ALSFRS-R score. A progressive decline in CST FA correlated with a decline in the ALSFRS-R score and worsening UMN signs. Patients with fast vs slow progression had a greater reduction in FA of the CST and upper frontal lobe.</AbstractText><AbstractText Label="CONCLUSIONS">Progressive WM degeneration in ALS is most prominent in the CST and frontal lobes and, to a lesser degree, in the corticopontine/corticorubral tracts and corticostriatal pathways. With the use of a harmonized imaging protocol and incorporation of analytic methods to address site-related variances, this study is an important milestone toward developing DTI biomarkers for cerebral degeneration in ALS.</AbstractText><AbstractText Label="CLINICALTRIALSGOV IDENTIFIER">NCT02405182.</AbstractText><CopyrightInformation>&#xa9; 2020 American Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kalra</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Division of Neurology (S.K.), Department of Medicine, Neuroscience and Mental Health Institute (S.K., A.I.), and Department of Biomedical Engineering (C.B.), University of Alberta, Edmonton, Canada; Department of Neurology (H.-P.M., J.K.), University of Ulm, Germany; Sunnybrook Health Sciences Centre (L.Z., S.J.G.), University of Toronto, Ontario; Departments of Clinical Neurosciences (L.K., R.F.) and Radiology (R.F.), Hotchkiss Brain Institute, University of Calgary, Alberta; Montreal Neurological Institute and Hospital (A.G.), McGill University, Quebec; and Seaman Family MR Research Centre (R.F.), Foothills Medical Centre, Calgary, Alberta, Canada. sanjay.kalra@ualberta.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Hans-Peter</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>From the Division of Neurology (S.K.), Department of Medicine, Neuroscience and Mental Health Institute (S.K., A.I.), and Department of Biomedical Engineering (C.B.), University of Alberta, Edmonton, Canada; Department of Neurology (H.-P.M., J.K.), University of Ulm, Germany; Sunnybrook Health Sciences Centre (L.Z., S.J.G.), University of Toronto, Ontario; Departments of Clinical Neurosciences (L.K., R.F.) and Radiology (R.F.), Hotchkiss Brain Institute, University of Calgary, Alberta; Montreal Neurological Institute and Hospital (A.G.), McGill University, Quebec; and Seaman Family MR Research Centre (R.F.), Foothills Medical Centre, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishaque</LastName><ForeName>Abdullah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Division of Neurology (S.K.), Department of Medicine, Neuroscience and Mental Health Institute (S.K., A.I.), and Department of Biomedical Engineering (C.B.), University of Alberta, Edmonton, Canada; Department of Neurology (H.-P.M., J.K.), University of Ulm, Germany; Sunnybrook Health Sciences Centre (L.Z., S.J.G.), University of Toronto, Ontario; Departments of Clinical Neurosciences (L.K., R.F.) and Radiology (R.F.), Hotchkiss Brain Institute, University of Calgary, Alberta; Montreal Neurological Institute and Hospital (A.G.), McGill University, Quebec; and Seaman Family MR Research Centre (R.F.), Foothills Medical Centre, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zinman</LastName><ForeName>Lorne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Division of Neurology (S.K.), Department of Medicine, Neuroscience and Mental Health Institute (S.K., A.I.), and Department of Biomedical Engineering (C.B.), University of Alberta, Edmonton, Canada; Department of Neurology (H.-P.M., J.K.), University of Ulm, Germany; Sunnybrook Health Sciences Centre (L.Z., S.J.G.), University of Toronto, Ontario; Departments of Clinical Neurosciences (L.K., R.F.) and Radiology (R.F.), Hotchkiss Brain Institute, University of Calgary, Alberta; Montreal Neurological Institute and Hospital (A.G.), McGill University, Quebec; and Seaman Family MR Research Centre (R.F.), Foothills Medical Centre, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korngut</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Division of Neurology (S.K.), Department of Medicine, Neuroscience and Mental Health Institute (S.K., A.I.), and Department of Biomedical Engineering (C.B.), University of Alberta, Edmonton, Canada; Department of Neurology (H.-P.M., J.K.), University of Ulm, Germany; Sunnybrook Health Sciences Centre (L.Z., S.J.G.), University of Toronto, Ontario; Departments of Clinical Neurosciences (L.K., R.F.) and Radiology (R.F.), Hotchkiss Brain Institute, University of Calgary, Alberta; Montreal Neurological Institute and Hospital (A.G.), McGill University, Quebec; and Seaman Family MR Research Centre (R.F.), Foothills Medical Centre, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Genge</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Division of Neurology (S.K.), Department of Medicine, Neuroscience and Mental Health Institute (S.K., A.I.), and Department of Biomedical Engineering (C.B.), University of Alberta, Edmonton, Canada; Department of Neurology (H.-P.M., J.K.), University of Ulm, Germany; Sunnybrook Health Sciences Centre (L.Z., S.J.G.), University of Toronto, Ontario; Departments of Clinical Neurosciences (L.K., R.F.) and Radiology (R.F.), Hotchkiss Brain Institute, University of Calgary, Alberta; Montreal Neurological Institute and Hospital (A.G.), McGill University, Quebec; and Seaman Family MR Research Centre (R.F.), Foothills Medical Centre, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaulieu</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the Division of Neurology (S.K.), Department of Medicine, Neuroscience and Mental Health Institute (S.K., A.I.), and Department of Biomedical Engineering (C.B.), University of Alberta, Edmonton, Canada; Department of Neurology (H.-P.M., J.K.), University of Ulm, Germany; Sunnybrook Health Sciences Centre (L.Z., S.J.G.), University of Toronto, Ontario; Departments of Clinical Neurosciences (L.K., R.F.) and Radiology (R.F.), Hotchkiss Brain Institute, University of Calgary, Alberta; Montreal Neurological Institute and Hospital (A.G.), McGill University, Quebec; and Seaman Family MR Research Centre (R.F.), Foothills Medical Centre, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frayne</LastName><ForeName>Richard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0358-1210</Identifier><AffiliationInfo><Affiliation>From the Division of Neurology (S.K.), Department of Medicine, Neuroscience and Mental Health Institute (S.K., A.I.), and Department of Biomedical Engineering (C.B.), University of Alberta, Edmonton, Canada; Department of Neurology (H.-P.M., J.K.), University of Ulm, Germany; Sunnybrook Health Sciences Centre (L.Z., S.J.G.), University of Toronto, Ontario; Departments of Clinical Neurosciences (L.K., R.F.) and Radiology (R.F.), Hotchkiss Brain Institute, University of Calgary, Alberta; Montreal Neurological Institute and Hospital (A.G.), McGill University, Quebec; and Seaman Family MR Research Centre (R.F.), Foothills Medical Centre, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graham</LastName><ForeName>Simon J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>From the Division of Neurology (S.K.), Department of Medicine, Neuroscience and Mental Health Institute (S.K., A.I.), and Department of Biomedical Engineering (C.B.), University of Alberta, Edmonton, Canada; Department of Neurology (H.-P.M., J.K.), University of Ulm, Germany; Sunnybrook Health Sciences Centre (L.Z., S.J.G.), University of Toronto, Ontario; Departments of Clinical Neurosciences (L.K., R.F.) and Radiology (R.F.), Hotchkiss Brain Institute, University of Calgary, Alberta; Montreal Neurological Institute and Hospital (A.G.), McGill University, Quebec; and Seaman Family MR Research Centre (R.F.), Foothills Medical Centre, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kassubek</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Division of Neurology (S.K.), Department of Medicine, Neuroscience and Mental Health Institute (S.K., A.I.), and Department of Biomedical Engineering (C.B.), University of Alberta, Edmonton, Canada; Department of Neurology (H.-P.M., J.K.), University of Ulm, Germany; Sunnybrook Health Sciences Centre (L.Z., S.J.G.), University of Toronto, Ontario; Departments of Clinical Neurosciences (L.K., R.F.) and Radiology (R.F.), Hotchkiss Brain Institute, University of Calgary, Alberta; Montreal Neurological Institute and Hospital (A.G.), McGill University, Quebec; and Seaman Family MR Research Centre (R.F.), Foothills Medical Centre, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02405182</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Neurology. 2020 Aug 25;95(8):327-328</RefSource><PMID Version="1">32646957</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011712" MajorTopicYN="N">Pyramidal Tracts</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="N">White Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32646955</ArticleId><ArticleId IdType="pmc">PMC7668555</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000010235</ArticleId><ArticleId IdType="pii">WNL.0000000000010235</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van den Berg LH, Sorenson E, Gronseth G, et al. . Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials. Neurology 2019;92:e1610&#x2013;e1623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6448453</ArticleId><ArticleId IdType="pubmed">30850440</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J, Pagani M. Imaging in amyotrophic lateral sclerosis: MRI and PET. Curr Opin Neurol 2019;32:740&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pubmed">31335337</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Schuff N, Woolley SC, et al. . Progression of white matter degeneration in amyotrophic lateral sclerosis: a diffusion tensor imaging study. Amyotroph Lateral Scler 2011;12:421&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3804304</ArticleId><ArticleId IdType="pubmed">21745124</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB, et al. . Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 2013;74:20&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J, M&#xfc;ller HP, Del Tredici K, et al. . Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology. Brain 2014;137:1733&#x2013;1740.</Citation><ArticleIdList><ArticleId IdType="pubmed">24736303</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J, M&#xfc;ller HP, Del Tredici K, et al. . Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker. J Neurol Neurosurg Psychiatry 2018;89:374&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5869447</ArticleId><ArticleId IdType="pubmed">29101254</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 1999;169:13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold G, Boone KB, Lu P, et al. . Sensitivity and specificity of finger tapping test scores for the detection of suspect effort. Clin Neuropsychol 2005;19:105&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">15814482</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo JH, Wang S, Melhem ER, et al. . Linear associations between clinically assessed upper motor neuron disease and diffusion tensor imaging metrics in amyotrophic lateral sclerosis. PLoS One 2014;9:e105753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4140827</ArticleId><ArticleId IdType="pubmed">25144708</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller HP, Unrath A, Ludolph AC, Kassubek J. Preservation of diffusion tensor properties during spatial normalization by use of tensor imaging and fibre tracking on a normal brain database. Phys Med Biol 2007;52:N99&#x2013;N109.</Citation><ArticleIdList><ArticleId IdType="pubmed">17327646</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller HP, Kassubek J. Diffusion tensor magnetic resonance imaging in the analysis of neurodegenerative diseases. J Vis Exp 2013;77:e50427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3846464</ArticleId><ArticleId IdType="pubmed">23928996</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller HP, Turner MR, Grosskreutz J, et al. . A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2016;87:570&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">26746186</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller HP, Unrath A, Sperfeld AD, et al. . Diffusion tensor imaging and tractwise fractional anisotropy statistics: quantitative analysis in white matter pathology. Biomed Eng Online 2007;6:42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2186341</ArticleId><ArticleId IdType="pubmed">17996104</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke RAL, K&#xf6;rner S, Filippini N, et al. . Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain 2014;137:2546&#x2013;2555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4132644</ArticleId><ArticleId IdType="pubmed">24951638</ArticleId></ArticleIdList></Reference><Reference><Citation>Brett M, Johnsrude IS, Owen AM. The problem of functional localization in the human brain. Nat Rev Neurosci 2002;3:243&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">11994756</ArticleId></ArticleIdList></Reference><Reference><Citation>Unrath A, M&#xfc;ller HP, Riecker A, et al. . Whole brain-based analysis of regional white matter tract alterations in rare motor neuron diseases by diffusion tensor imaging. Hum Brain Mapp 2010;31:1727&#x2013;1740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6871219</ArticleId><ArticleId IdType="pubmed">20336652</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller HP, Unrath A, Huppertz HJ, et al. . Neuroanatomical patterns of cerebral white matter involvement in different motor neuron diseases as studied by diffusion tensor imaging analysis. Amyotroph Lateral Scler 2012;13:254&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">22409361</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosskopf J, M&#xfc;ller HP, Dreyhaupt J, et al. . Ex post facto assessment of diffusion tensor imaging metrics from different MRI protocols: preparing for multicentre studies in ALS. Amyotroph Lateral Scler Front Degener 2015;16:92&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">25574564</ArticleId></ArticleIdList></Reference><Reference><Citation>Salat DH, Tuch DS, Greve DN, et al. . Age-related alterations in white matter microstructure measured by diffusion tensor imaging. Neurobiol Aging 2005;26:1215&#x2013;1227.</Citation><ArticleIdList><ArticleId IdType="pubmed">15917106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S, Han CE, Uhlhaas PJ, Kaiser M. Preferential detachment during human brain development: age- and sex-specific structural connectivity in diffusion tensor imaging (DTI) data. Cereb Cortex 2015;25:1477&#x2013;1489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4428296</ArticleId><ArticleId IdType="pubmed">24343892</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J, M&#xfc;ller HP. Computer-based magnetic resonance imaging as a tool in clinical diagnosis in neurodegenerative diseases. Expert Rev Neurother 2016;16:295&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">26807776</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller HP, Kassubek J. MRI-based mapping of cerebral propagation in amyotrophic lateral sclerosis. Front Neurosci 2018;12:655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6168650</ArticleId><ArticleId IdType="pubmed">30319338</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller HP, Unrath A, Riecker A, et al. . Intersubject variability in the analysis of diffusion tensor images at the group level: fractional anisotropy mapping and fiber tracking techniques. Magn Reson Imaging 2009;27:324&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pubmed">18701228</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunimatsu A, Aoki S, Masutani Y, et al. . The optimal trackability threshold of fractional anisotropy for diffusion tensor tractography of the corticospinal tract. Magn Reson Med Sci 2004;3:11&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">16093615</ArticleId></ArticleIdList></Reference><Reference><Citation>Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002;15:870&#x2013;878.</Citation><ArticleIdList><ArticleId IdType="pubmed">11906227</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke RAL, Agosta F, Grosskreutz J, et al. . Neuroimaging endpoints in amyotrophic lateral sclerosis. Neurotherapeutics 2017;14:11&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5233627</ArticleId><ArticleId IdType="pubmed">27752938</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Agosta F, Bede P, et al. . Neuroimaging in amyotrophic lateral sclerosis. Biomark Med 2012;6:319&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pubmed">22731907</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, B&#xf6;hm S, M&#xfc;ller HP, et al. . Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis. Cortex 2018;101:163&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">29477906</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldaranov D, Khomenko A, Kobor I, et al. . Longitudinal diffusion tensor imaging-based assessment of tract alterations: an application to amyotrophic lateral sclerosis. Front Hum Neurosci 2017;11:567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5723297</ArticleId><ArticleId IdType="pubmed">29259550</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardenas-Blanco A, Machts J, Acosta-Cabronero J, et al. . Structural and diffusion imaging versus clinical assessment to monitor amyotrophic lateral sclerosis. Neuroimage Clin 2016;11:408&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4827722</ArticleId><ArticleId IdType="pubmed">27104135</ArticleId></ArticleIdList></Reference><Reference><Citation>Keil C, Prell T, Peschel T, et al. . Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis. BMC Neurosci 2012;13:141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3531302</ArticleId><ArticleId IdType="pubmed">23134591</ArticleId></ArticleIdList></Reference><Reference><Citation>de Albuquerque M, Branco LMT, Rezende TJR, et al. . Longitudinal evaluation of cerebral and spinal cord damage in amyotrophic lateral sclerosis. Neuroimage Clin 2017;14:269&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5294732</ArticleId><ArticleId IdType="pubmed">28203530</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Kiernan MC, Leigh PN, Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 2009;8:94&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">19081518</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete E, Turner MR, Grosskreutz J, et al. . Mind the gap: the mismatch between clinical and imaging metrics in ALS. Amyotroph Lateral Scler Front Degener 2015;16:524&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pubmed">26402254</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishaque A, Mah D, Seres P, et al. . Evaluating the cerebral correlates of survival in amyotrophic lateral sclerosis. Ann Clin Transl Neurol 2018;5:1350&#x2013;1361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6243384</ArticleId><ArticleId IdType="pubmed">30480029</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Hardiman O, et al. . Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 2009;10:310&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke RAL, Abraham I, Thiel CS, et al. . Fractional anisotropy in the posterior limb of the internal capsule and prognosis in amyotrophic lateral sclerosis. Arch Neurol 2012;69:1493.</Citation><ArticleIdList><ArticleId IdType="pubmed">22910997</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete E, Veldink JH, Hendrikse J, et al. . Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2012;83:383&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">21965521</ArticleId></ArticleIdList></Reference><Reference><Citation>d'Ambrosio A, Gallo A, Trojsi F, et al. . Frontotemporal cortical thinning in amyotrophic lateral sclerosis. Am J Neuroradiol 2014;35:304&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7965753</ArticleId><ArticleId IdType="pubmed">24113470</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JY, Abdi H, Bakhadirov K, et al. . A comprehensive reliability assessment of quantitative diffusion tensor tractography. Neuroimage 2012;60:1127&#x2013;1138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3468740</ArticleId><ArticleId IdType="pubmed">22227883</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole JH, Farmer RE, Rees EM, et al. . Test-retest reliability of diffusion tensor imaging in Huntington's disease. PLoS Curr 2014;6:ecurrents.hd.f19ef63fff962f5cd9c0e88f4844f43b.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3962450</ArticleId><ArticleId IdType="pubmed">24672743</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollmar C, O'Muircheartaigh J, Barker GJ, et al. . Identical, but not the same: intra-site and inter-site reproducibility of fractional anisotropy measures on two 3.0T scanners. Neuroimage 2010;51:1384&#x2013;1394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3163823</ArticleId><ArticleId IdType="pubmed">20338248</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>